Radiopharmaceutical development of radiolabelled peptides.
about
Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple IntegrinsRadiolabeled cyclic RGD peptides as radiotracers for tumor imagingInsights into bombesin receptors and ligands: Highlighting recent advancesCyclopeptides containing the DEKS motif as conformationally restricted collagen telopeptide analogues: synthesis and conformational analysis.Design and applications of bispecific heterodimers: molecular imaging and beyondHeterobivalent dual-target probe for targeting GRP and Y1 receptors on tumor cellsA new automated NaCl based robust method for routine production of gallium-68 labeled peptides.18F-glutathione conjugate as a PET tracer for imaging tumors that overexpress L-PGDS enzyme.Cyclic RGD Peptides Incorporating Cycloalkanes: Synthesis and Evaluation as PET Radiotracers for Tumor Imaging.FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues.High efficiency diffusion molecular retention tumor targeting.Synthesis and preliminary evaluation of a new (99m)tc labeled substance p analogue as a potential tumor imaging agent.Preclinical Evaluation of a Potential GSH Ester Based PET/SPECT Imaging Probe DT(GSHMe)₂ to Detect Gamma Glutamyl Transferase Over Expressing Tumors.Absorption, distribution and excretion of intravenously injected (68)Ge/ (68)Ga generator eluate in healthy rats, and estimation of human radiation dosimetryEvaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in InsulinomaSynthesis and antimicrobial evaluation of two peptide LyeTx I derivatives modified with the chelating agent HYNIC for radiolabeling with technetium-99m.Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PET.Microfluidics for synthesis of peptide-based PET tracers.A 99mTc-tricine-HYNIC-labeled Peptide Targeting the Melanocortin-1 Receptor for Melanoma Imaging.Radiolabeled bombesin derivatives for preclinical oncological imaging.Tumour targeting with radiometals for diagnosis and therapy.SPECT- and PET-based approaches for noninvasive diagnosis of acute renal allograft rejection.Methoxinine - an alternative stable amino acid substitute for oxidation-sensitive methionine in radiolabelled peptide conjugates.Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?(99m)Tc-bioorthogonal click chemistry reagent for in vivo pretargeted imaging.Evaluation of (99m)Tc-HYNIC-βAla-Bombesin(7-14) as an agent for pancreas tumor detection in mice.Microfluidics in the selection of affinity reagents for the detection of cancer: paving a way towards future diagnostics.Technetium-99m radiolabeled paclitaxel as an imaging probe for breast cancer in vivoA high-affinity near-infrared fluorescent probe to target bombesin receptors.Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging.Preclinical Study of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human OrgansMetal-Based PSMA Radioligands.New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.The in vivo disposition and in vitro transmembrane transport of two model radiometabolites of DOTA-conjugated receptor-specific peptides labelled with (177) Lu.Radiosynthesis of clinical doses of ⁶⁸Ga-DOTATATE (GalioMedix™) and validation of organic-matrix-based ⁶⁸Ge/⁶⁸Ga generators.Comment on Pepe et al.: somatostatin receptor SPECTPast, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX.Novel peptide probes to assess the tensional state of fibronectin fibers in cancer.Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN7-14 and Antagonist RM26.In Vivo Evaluation of a Bombesin Analogue Labeled with Ga-68 and Co-55/57.
P2860
Q26801806-59A6D948-B78D-40F1-AE5E-14D334CB3247Q28072021-A8296BDC-CE47-4A06-83C9-C650F7771250Q28081153-7C6D15E0-9BDD-4CDC-ADA1-34D7EEA0B61AQ30878012-B7D53709-3E2D-4D33-925F-19F2B0C92C4DQ33732587-90CF90F3-B5A8-4250-9D3D-BDFCE2BA2C40Q33804178-170AF599-52E9-48C8-8D64-E1D0060D536FQ33896997-412BB244-11A6-4E84-9E1F-FCF6BE73B385Q34027558-0C1501D4-77E4-4135-A0A8-F3B663F6E388Q34162650-B145E810-90C2-4967-8DB8-B4C66B551546Q34556242-74101341-4E6D-4AF4-BDEF-1826485D4311Q34625694-3D7A224A-B962-45F4-B211-5BA0DBD4A918Q34777749-B00B1A66-0C97-424F-9425-4643625E61C7Q35722230-C495E779-A79F-4902-B9F5-E577AD839206Q35858931-0DF5B823-CBAB-482F-8F4F-120EBD846A2EQ36383709-F62074C3-B044-44C1-ADA7-9B498CED88AAQ36825789-49D6B007-DD5A-4EF0-9845-62DCA120C297Q37112967-889B2CE6-1ADB-474D-88DC-52B3F9F57202Q37322485-9BCFAAF1-9461-49A7-9AF5-81324D8C87DEQ37491293-EE35DC9E-621D-4A96-8B89-AF02648AC51AQ37674035-94445D38-E40C-4EE9-B20B-4D960327D84AQ38100112-63784E83-AC13-403B-A7B6-CB55819FB1E3Q38209944-8109CAD0-033D-44A5-AE00-E705FD2C2C9DQ38722877-6197F508-DB52-49B5-8E7C-296AF6E88497Q38755295-F75F28B7-E460-4DC6-AB9E-5C2016AD62F9Q38794260-C4B4AC53-5982-4D21-B29D-F01205A39013Q38829691-794352D7-6AE7-45E3-A186-010FA5F19700Q38844919-BE55044E-21CE-427F-A7F1-595C3278A034Q38949920-C49EC194-FA3F-4E02-99C0-4AE30A7D273FQ39017820-E3C59565-CD80-4591-883F-B00EA2D8260CQ39037392-F38D5C61-5DD2-46FE-866E-21F662B6A849Q39140677-793DBF9C-EB95-47D5-B885-E8F428FA66DCQ39198527-372B8A79-91D9-46E7-B114-C2775D9ACD31Q40098290-A64F6435-0942-483F-9C9E-FA69F6B0E21DQ40364919-85CB21F4-526D-4909-89E7-7D8124DAAE14Q41201900-C722D12D-B800-4BFE-B506-85B494772057Q42646397-E5556793-0756-4BA6-A2D0-6620631769C5Q47097799-4E7DEDF6-6A8A-4808-AC4C-0214CF6F67E5Q47117973-4FC3247E-DC0B-42BC-9F3F-1E04CD3B0E5AQ48098858-D3F2D3B7-388A-4DE0-A150-FC2ECE58A9C8Q48105870-7F545B5D-572D-4AE0-A256-BF829EB6D7B6
P2860
Radiopharmaceutical development of radiolabelled peptides.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Radiopharmaceutical development of radiolabelled peptides.
@en
Radiopharmaceutical development of radiolabelled peptides.
@nl
type
label
Radiopharmaceutical development of radiolabelled peptides.
@en
Radiopharmaceutical development of radiolabelled peptides.
@nl
prefLabel
Radiopharmaceutical development of radiolabelled peptides.
@en
Radiopharmaceutical development of radiolabelled peptides.
@nl
P2860
P1476
Radiopharmaceutical development of radiolabelled peptides.
@en
P2093
Helmut R Maecke
Melpomeni Fani
P2860
P2888
P304
P356
10.1007/S00259-011-2001-Z
P478
39 Suppl 1
P577
2012-02-01T00:00:00Z